{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:04:35Z","timestamp":1791594275115,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171662"],"award-info":[{"award-number":["82171662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401985"],"award-info":[{"award-number":["82401985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704702"],"award-info":[{"award-number":["2022YFC2704702"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFQ0005"],"award-info":[{"award-number":["2023YFQ0005"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.placenta.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:47:56Z","timestamp":1749469676000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Safety assessment of drugs in pregnancy: An update of pharmacological models"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-2780","authenticated-orcid":false,"given":"Lunbo","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisheng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.placenta.2025.06.007_bib1","doi-asserted-by":"crossref","first-page":"e1174","DOI":"10.1016\/S2214-109X(24)00144-X","article-title":"The drug drought in maternal health: an ongoing predicament","volume":"12","author":"Ammerdorffer","year":"2024","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib2","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0050022","article-title":"Market failure and the poverty of new drugs in maternal health","volume":"5","author":"Fisk","year":"2008","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.placenta.2025.06.007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166131","article-title":"Dynamic placenta-on-a-chip model for fetal risk assessment of nanoparticles intended to treat pregnancy-associated diseases","volume":"1867","author":"Shojaei","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.placenta.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fphar.2012.00126","article-title":"Drug interactions at the human placenta: what is the evidence?","volume":"3","author":"Rubinchik-Stern","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.placenta.2025.06.007_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17425255.2024.2420195","article-title":"Optimizing drug therapy during pregnancy: a spotlight on population pharmacokinetic modeling","volume":"21","author":"Dodeja","year":"2025","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1753495X231163351","article-title":"Walking the walk to include pregnant participants in non-obstetric clinical trials: insights from the SNAP Trial","volume":"16","author":"Malhame","year":"2023","journal-title":"Obstet. Med."},{"issue":"4","key":"10.1016\/j.placenta.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10928-020-09687-z","article-title":"Challenges in conducting clinical research studies in pregnant women","volume":"47","author":"McKiever","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"11","key":"10.1016\/j.placenta.2025.06.007_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11920-022-01372-x","article-title":"Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: an updated review on risks to mother, fetus, and child","volume":"24","author":"Lebin","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"issue":"4","key":"10.1016\/j.placenta.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1248\/bpb.b25-00016","article-title":"Safety assessment of medications during pregnancy and breastfeeding based on quantitative and toxicological analyses","volume":"48","author":"Furugen","year":"2025","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.placenta.2025.06.007_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-based lamotrigine clearance changes during pregnancy: clinical implication","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.placenta.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","article-title":"Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists","volume":"82","author":"Quan","year":"2006","journal-title":"Early Hum. Dev."},{"issue":"22","key":"10.1016\/j.placenta.2025.06.007_bib14","doi-asserted-by":"crossref","DOI":"10.1242\/dev.163428","article-title":"Development of the human placenta","volume":"146","author":"Turco","year":"2019","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.placenta.2025.06.007_bib15","first-page":"140","article-title":"Thalidomide-induced teratogenesis: history and mechanisms, birth defects res C embryo","volume":"105","author":"Vargesson","year":"2015","journal-title":"Todays Off. (Garden City, N. Y.)"},{"key":"10.1016\/j.placenta.2025.06.007_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.placenta.2021.09.011","article-title":"The road (not) taken - placental transfer and interspecies differences","volume":"115","author":"Schmidt","year":"2021","journal-title":"Placenta (Eastbourne)"},{"issue":"11\u201312","key":"10.1016\/j.placenta.2025.06.007_bib17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.placenta.2005.11.012","article-title":"Transport of glyburide by placental ABC transporters: implications in fetal drug exposure","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta (Eastbourne)"},{"issue":"4","key":"10.1016\/j.placenta.2025.06.007_bib18","first-page":"266","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology (Bethesda, Md.)"},{"issue":"3","key":"10.1016\/j.placenta.2025.06.007_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501462","article-title":"A three-dimensional culture system recapitulates placental syncytiotrophoblast development and microbial resistance","volume":"2","author":"McConkey","year":"2016","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010096","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by metabolism in pregnant subjects and fetuses","volume":"16","author":"Le Merdy","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.placenta.2025.06.007_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s40262-017-0594-5","article-title":"A physiologically based pharmacokinetic model for pregnant women to predict the pharmacokinetics of drugs metabolized via several enzymatic pathways","volume":"57","author":"Dallmann","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2025.06.007_bib22","first-page":"S188","article-title":"Translating clinical pharmacology data in pregnancy to evidence-based guideline recommendations: perspectives from the HIV field","volume":"63","author":"Brooks","year":"2023","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajog.2021.04.227","article-title":"Drug development research in pregnant and lactating women","volume":"225","author":"Ren","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib24","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0008","article-title":"Rising STARS: approaches to modeling placental function in preeclampsia in vitro and in vivo","volume":"258","author":"Milano-Foster","year":"2023","journal-title":"J. Endocrinol."},{"issue":"7735","key":"10.1016\/j.placenta.2025.06.007_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41586-018-0753-3","article-title":"Trophoblast organoids as a model for maternal-fetal interactions during human placentation","volume":"564","author":"Turco","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.placenta.2025.06.007_bib26","doi-asserted-by":"crossref","first-page":"jcs261528","DOI":"10.1242\/jcs.261528","article-title":"Trophoblast organoids with physiological polarity model placental structure and function","volume":"137","author":"Yang","year":"2024","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.placenta.2025.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117112","article-title":"Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport","volume":"492","author":"Huang","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41419-025-07400-x","article-title":"Genetically edited human placental organoids cast new light on the role of ACE2","volume":"16","author":"Arthurs","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.placenta.2025.06.007_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.placenta.2022.05.003","article-title":"Ex vivo dual perfusion of an isolated human placenta cotyledon: towards protocol standardization and improved inter-centre comparability","volume":"126","author":"Schneider","year":"2022","journal-title":"Placenta (Eastbourne)"},{"key":"10.1016\/j.placenta.2025.06.007_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.toxlet.2018.07.012","article-title":"Transplacental transfer and metabolism of diuron in human placenta","volume":"295","author":"Mohammed","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.placenta.2025.06.007_bib31","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1111\/epi.17778","article-title":"Placental disposition of cannabidiol: an ex vivo perfusion study","volume":"64","author":"Berman","year":"2023","journal-title":"Epilepsia (Cph.)"},{"issue":"4","key":"10.1016\/j.placenta.2025.06.007_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/HYPERTENSIONAHA.123.22457","article-title":"Statins prevent the deleterious consequences of placental chemerin upregulation in preeclampsia","volume":"81","author":"Tan","year":"2024","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2025.06.007_bib33","article-title":"Placental drug transport-on-a-chip: a microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier","volume":"7","author":"Blundell","year":"2018","journal-title":"Adv. Healthcare Mater."},{"issue":"5","key":"10.1016\/j.placenta.2025.06.007_bib34","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2019.0031","article-title":"Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches","volume":"9","author":"Pemathilaka","year":"2019","journal-title":"Interface Focus"},{"issue":"7","key":"10.1016\/j.placenta.2025.06.007_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3109\/14767058.2015.1038518","article-title":"Placenta-on-a-chip: a novel platform to study the biology of the human placenta","volume":"29","author":"Lee","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.placenta.2025.06.007_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S2040174416000611","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) expression very early during human pregnancy","volume":"8","author":"Salvante","year":"2017","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/j.placenta.2025.06.007_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bcp.2018.09.012","article-title":"Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin","volume":"156","author":"Afrouzian","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.placenta.2025.06.007_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.placenta.2025.06.007_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107240","article-title":"Development of a human iPSC-derived placental barrier-on-chip model","volume":"26","author":"Lermant","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.placenta.2025.06.007_bib40","article-title":"An extra-uterine system to physiologically support the extreme premature lamb","volume":"8","author":"Partridge","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.placenta.2025.06.007_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1219185","article-title":"Artificial placenta support of extremely preterm ovine fetuses at the border of viability for up to 336 hours with maintenance of systemic circulation but reduced somatic and organ growth","volume":"14","author":"Usuda","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.placenta.2025.06.007_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12947","article-title":"A volume-adjustable artificial womb for extremely preterm infants","volume":"37","author":"Heyer","year":"2024","journal-title":"Transpl. Int."},{"key":"10.1016\/j.placenta.2025.06.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2022.12.004","article-title":"High-throughput screening of toxicants that modulate extravillous trophoblast migration","volume":"375","author":"Meakin","year":"2023","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.placenta.2025.06.007_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s43856-023-00329-2","article-title":"Toxicology knowledge graph for structural birth defects","volume":"3","author":"Evangelista","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.placenta.2025.06.007_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1275467","article-title":"In silico modeling for ex vivo placenta perfusion of nicotine","volume":"15","author":"Ho","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:54:10Z","timestamp":1780862050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"alternative-id":["S0143400425002140"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.06.007","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety assessment of drugs in pregnancy: An update of pharmacological models","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}